Long-term population-based risks of breast cancer after childhood cancer

International Journal of Cancer. Journal International Du Cancer
Raoul C ReulenBritish Childhood Cancer Survivor Study The British Childhood Cancer Survivor Study (BCCSS) Steering Group

Abstract

Previous studies have reported substantially increased risks of breast cancer among survivors of childhood cancer at 10-20 years posttreatment. Whether these excess risks are sustained beyond 40 years of age when general population incidence of breast cancer begins its steep increase is largely unknown. We quantified the risk of breast cancer in adult female survivors with considerably more survivors followed-up beyond 40 years of age than previously available. Standardized Incidence Ratios (SIR), Excess Absolute Risks (EAR), and cumulative incidence were calculated within a population-based cohort of 8,093 female survivors of childhood cancer. Poisson regression models were used to model SIRs and EARs in a multivariable setting. Eighty-one survivors developed a primary breast cancer, where 37.5 were expected (SIR= 2.2, 95% CI: 1.7-2.7). SIRs decreased significantly with increasing attained age (p(trend) < 0.001) to an SIR of 0.9 (95% CI: 0.5-1.8) at ages beyond 50 years; EARs increased significantly to about 40 years of age (p(trend) < 0.001) but then plateau. Between 30 and 49 years of age survivors experienced approximately 1 extra breast cancer per 1,000 survivors per year. Overall, 3% developed breast cancer by the age of ...Continue Reading

References

Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N E BreslowD M Green
Mar 21, 1996·The New England Journal of Medicine·S BhatiaA T Meadows
Oct 23, 1997·JAMA : the Journal of the American Medical Association·F L WongF P Li
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F E van LeeuwenB M Aleman
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J SwerdlowD C Linch
Jun 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C MetayerL B Travis
Apr 20, 2001·Journal of the National Cancer Institute·J P NegliaL L Robison
Jul 24, 2003·JAMA : the Journal of the American Medical Association·Lois B TravisEthel Gilbert
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Smita BhatiaUNKNOWN Late Effects Study Group
Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Mar 5, 2004·Journal of the National Cancer Institute·Olivia FletcherJulian Peto
Oct 20, 2004·Annals of Internal Medicine·Lisa B KenneyLisa Diller
Nov 10, 2004·British Journal of Cancer·H C JenkinsonM C G Stevens
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine GuiboutFlorent de Vathaire
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ruth A KleinermanJoseph F Fraumeni
Oct 13, 2006·The New England Journal of Medicine·Kevin C OeffingerUNKNOWN Childhood Cancer Survivor Study
Oct 27, 2006·International Journal of Cancer. Journal International Du Cancer·Aliki J TaylorMike M Hawkins
Jun 9, 2007·International Journal of Cancer. Journal International Du Cancer·Peter D Inskip, Rochelle E Curtis
Jan 16, 2008·International Journal of Cancer. Journal International Du Cancer·Aliki J TaylorUNKNOWN British Childhood Cancer Survivor Study

❮ Previous
Next ❯

Citations

May 28, 2009·Journal of the National Cancer Institute·Jørgen H OlsenStanislaw Garwicz
Oct 5, 2010·The Cancer Journal·A Robert Kagan, Robert J Schulz
Feb 18, 2014·BMC Cancer·Jérémie JéguMichel Velten
Dec 2, 2015·International Journal of Clinical Oncology·Yasushi IshidaTatsuo Kuroda
Jan 22, 2011·Pediatric Blood & Cancer·Christopher Fryer
Mar 19, 2014·International Journal of Epidemiology·Julie BerbisSandrine Thouvenin-Doulet
May 28, 2016·Endocrine-related Cancer·Mark WijnenSebastian Neggers
Dec 25, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tara O HendersonKevin C Oeffinger
Feb 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Flora E van Leeuwen, Cécile M Ronckers
Jun 24, 2015·Journal of Applied Clinical Medical Physics·Michael D Mills, Robert J Schulz
Dec 1, 2017·European Journal of Epidemiology·Peter Haubjerg AsdahlUNKNOWN ALiCCS study group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Statistics in Medicine
Paul W DickmanTimo Hakulinen
International Journal of Cancer. Journal International Du Cancer
Cristina BosettiPaolo Boffetta
JAMA : the Journal of the American Medical Association
Raoul C ReulenBritish Childhood Cancer Survivor Study Steering Group
© 2022 Meta ULC. All rights reserved